睡眠補助薬市場：製品別、睡眠障害別、流通チャネル別-2025-2030年世界予測

睡眠補助薬市場の2023年の市場規模は593億2,000万米ドルで、2024年には641億5,000万米ドルに達すると予測され、CAGR 5.98％で成長し、2030年には891億1,000万米ドルに達すると予測されています。

睡眠補助薬市場には、個人がより良い睡眠を得られるように設計された様々な製品とサービスが含まれます。このカテゴリーには、鎮静剤や催眠剤などの医薬品、メラトニンサプリメントなどの市販薬、スマート睡眠マスクや睡眠追跡アプリなどのデバイスが含まれます。睡眠補助薬の必要性は、不眠症、睡眠時無呼吸症候群、その他の睡眠障害が、ストレスの多い目まぐるしいライフスタイルによって悪化していることから生じています。その用途はヘルスケア施設、ウェルネスセンター、自宅での個人使用など多岐にわたる。エンドユーザーには、睡眠問題に悩む成人、自然な睡眠の低下に直面する高齢者層、さらにはスクリーンタイムに影響されるティーンエイジャーが含まれます。市場成長の原動力となっているのは、睡眠の重要性に対する意識の高まり、睡眠障害の発生率の上昇、睡眠技術の進歩です。しかし、睡眠薬依存の汚名や副作用の懸念も影響しています。ホリスティックな健康法への国民のシフトを反映し、ハーブサプリメントやデジタル治療薬のような自然で代替的な睡眠ソリューションに大きなチャンスがあります。非中毒性の睡眠補助薬やユーザーフレンドリーな睡眠テクノロジーの研究開発への投資などが推奨されます。市場は、医薬品の厳しい規制、ユーザーニーズの多様性、瞑想やヨガのような伝統的な習慣との競合といった課題に直面しています。より正確な睡眠トラッキングのためのバイオセンサー、AIを活用したパーソナライズされた睡眠ソリューション、複数の健康指標のデータを組み合わせた統合型アプリなど、イノベーションは熟しています。市場力学はダイナミックで、急速な技術進歩と、日常生活にシームレスに適合する安全で効果的なソリューションへの強い嗜好を特徴としています。この進化する情勢を活用するために、企業は医療用と非医療用の両方の睡眠改善ソリューションを求める多様な消費者層に対応する多用途の製品ラインを構築することに注力すべきです。

市場力学：急速に進化する睡眠補助薬市場の主要市場インサイトを公開

睡眠補助薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • さまざまな睡眠状態の治療・診断ニーズの高まり
  • 睡眠障害に対する人々の意識の高まり
  • ウェアラブルセンサーとトラッキングデバイスの受け入れ拡大
• 市場抑制要因
  • 睡眠補助装置の不適切なキャリブレーション
• 市場機会
  • 睡眠補助機器における新技術のイントロダクション
  • 巨大な睡眠補助薬を入札するための研究開発（R&D）に対する政府資金の増加
• 市場の課題
  • 許認可のための適切な書類の欠如

ポーターのファイブフォース：睡眠補助薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、睡眠補助薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：睡眠補助薬市場における外部からの影響の把握

外部マクロ環境要因は、睡眠補助薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析睡眠補助薬市場における競合情勢の把握

睡眠補助薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス睡眠補助薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、睡眠補助薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨睡眠補助薬市場における成功への道筋を描く

睡眠補助薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • さまざまな睡眠障害の治療と診断の必要性が高まっている
    • 睡眠障害に対する国民の意識の高まり
    • ウェアラブルセンサーと追跡デバイスの普及拡大
  • 抑制要因
    • 睡眠補助装置の不適切な調整
  • 機会
    • 睡眠補助剤における新技術のイントロダクション
    • 研究開発（R&D）への政府資金の増加が巨額の入札を招いている睡眠補助薬
  • 課題
    • 許可ライセンスに必要な適切な文書がない
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 睡眠補助薬市場：製品別

• マットレスと枕
• 医薬品
  • ハーブ薬
  • 市販薬
  • 処方薬
• 睡眠時無呼吸症候群用デバイス
  • 適応型サーボ人工呼吸器（ASV）
  • フェイシャルインターフェース
  • 口腔装置
  • 気道陽圧（PAP）装置

第7章 睡眠補助薬市場睡眠障害

• 不眠症
• ナルコレプシー
• むずむず脚症候群
• 睡眠時無呼吸症候群
• 夢遊病

第8章 睡眠補助薬市場：流通チャネル別

• ドラッグストア
• eコマース
• 病院薬局
• 小売薬局

第9章 南北アメリカの睡眠補助薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の睡眠補助薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの睡眠補助薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Apnea Sciences Corporation
• Boehringer Ingelheim International GmbH
• Cadwell Industries Inc.
• Cleveland Medical Devices Inc.
• Compumedics Limited
• Drive DeVilbiss Healthcare Inc.
• Eisai Co., Ltd.
• Fisher & Paykel Healthcare Corp. Ltd.
• Koninklijke Philips N. V.
• Merck and Co. Inc.
• Natus Medical Inc.
• Nihon Kohden Corporation
• Pfizer Inc.
• ResMed Inc.
• Sanofi S.A.

LIST OF FIGURES

• FIGURE 1. SLEEP AIDS MARKET RESEARCH PROCESS
• FIGURE 2. SLEEP AIDS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SLEEP AIDS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SLEEP AIDS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SLEEP AIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SLEEP AIDS MARKET DYNAMICS
• TABLE 7. GLOBAL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SLEEP AIDS MARKET SIZE, BY MATTRESSES & PILLOWS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SLEEP AIDS MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SLEEP AIDS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SLEEP AIDS MARKET SIZE, BY PRESCRIPTION-BASED DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SLEEP AIDS MARKET SIZE, BY ADAPTIVE SERVO-VENTILATORS (ASVS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SLEEP AIDS MARKET SIZE, BY FACIAL INTERFACES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SLEEP AIDS MARKET SIZE, BY ORAL APPLIANCES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SLEEP AIDS MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SLEEP AIDS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SLEEP AIDS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SLEEP AIDS MARKET SIZE, BY RESTLESS LEGS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SLEEP AIDS MARKET SIZE, BY SLEEP WALKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SLEEP AIDS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SLEEP AIDS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SLEEP AIDS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SLEEP AIDS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. CANADA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CANADA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 49. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. CANADA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 51. CANADA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES SLEEP AIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. CHINA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. CHINA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 76. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. CHINA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 78. CHINA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. INDIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. INDIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 81. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. INDIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 83. INDIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA SLEEP AIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. ITALY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. ITALY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 167. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. ITALY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 169. ITALY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. POLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. POLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 187. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. POLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 189. POLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 190. QATAR SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. QATAR SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 192. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. QATAR SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 194. QATAR SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP APNEA DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY SLEEP-DISORDER, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM SLEEP AIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 240. SLEEP AIDS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. SLEEP AIDS MARKET, FPNV POSITIONING MATRIX, 2023

The Sleep Aids Market was valued at USD 59.32 billion in 2023, expected to reach USD 64.15 billion in 2024, and is projected to grow at a CAGR of 5.98%, to USD 89.11 billion by 2030.

The sleep aids market encompasses a variety of products and services designed to help individuals achieve better sleep. This category includes pharmaceuticals like sedatives and hypnotics, over-the-counter remedies such as melatonin supplements, and devices like smart sleep masks and sleep tracking apps. The necessity for sleep aids arises from the prevalent issues of insomnia, sleep apnea, and other sleep disorders exacerbated by increasingly stressful and fast-paced lifestyles. Their application spans healthcare facilities, wellness centers, and individual use at home. End users include adults struggling with sleep problems, older demographics facing natural sleep decline, and even teenagers affected by screen time. Market growth is driven by increasing awareness of the importance of sleep, rising incidence of sleep disorders, and advancements in sleep technology. However, it's also influenced by the stigma of dependence on sleep medications and concerns about side effects. A significant opportunity lies in natural and alternative sleep solutions like herbal supplements and digital therapeutics, reflecting a public shift toward holistic health practices. Recommendations include investing in research and development of non-addictive sleep aids and user-friendly sleep technology. The market faces challenges such as stringent regulations in pharmaceuticals, variability in user needs, and competition from traditional practices like meditation and yoga. Innovation is ripe in biosensors for more accurate sleep tracking, AI-driven personalized sleep solutions, and integrative apps that combine data from multiple health metrics. The sleep aids market is dynamic, characterized by rapid technological advancements and a strong preference for safe, effective solutions that fit seamlessly into daily life. To capitalize on this evolving landscape, companies should focus on building versatile product lines that cater to a diverse consumer base seeking both medical and non-medical sleep improvement solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sleep Aids Market

The Sleep Aids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for treating & diagnosing different forms of sleep conditions
  • Rising public awareness of the sleep disorders
  • Growing acceptance of wearable sensors and tracking devices
• Market Restraints
  • Inappropriate calibration of devices of sleeping aids
• Market Opportunities
  • Introduction of novel technologies in sleeping aids
  • Growing government funding for research & development (R&D) to bid huge sleep aids
• Market Challenges
  • Absence of appropriate documents for the permitting license

Porter's Five Forces: A Strategic Tool for Navigating the Sleep Aids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sleep Aids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sleep Aids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sleep Aids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sleep Aids Market

A detailed market share analysis in the Sleep Aids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sleep Aids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sleep Aids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sleep Aids Market

A strategic analysis of the Sleep Aids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sleep Aids Market, highlighting leading vendors and their innovative profiles. These include Apnea Sciences Corporation, Boehringer Ingelheim International GmbH, Cadwell Industries Inc., Cleveland Medical Devices Inc., Compumedics Limited, Drive DeVilbiss Healthcare Inc., Eisai Co., Ltd., Fisher & Paykel Healthcare Corp. Ltd., Koninklijke Philips N. V., Merck and Co. Inc., Natus Medical Inc., Nihon Kohden Corporation, Pfizer Inc., ResMed Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Sleep Aids Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Mattresses & Pillows, Medications, and Sleep Apnea Devices. The Medications is further studied across Herbal Drugs, OTC Drugs, and Prescription-Based Drugs. The Sleep Apnea Devices is further studied across Adaptive Servo-Ventilators (ASVs), Facial Interfaces, Oral Appliances, and Positive Airway Pressure (PAP) Devices.
• Based on Sleep-Disorder, market is studied across Insomnia, Narcolepsy, Restless Legs Syndrome, Sleep Apnea, and Sleep Walking.
• Based on Distribution Channel, market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for treating & diagnosing different forms of sleep conditions
    • 5.1.1.2. Rising public awareness of the sleep disorders
    • 5.1.1.3. Growing acceptance of wearable sensors and tracking devices
  • 5.1.2. Restraints
    • 5.1.2.1. Inappropriate calibration of devices of sleeping aids
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of novel technologies in sleeping aids
    • 5.1.3.2. Growing government funding for research & development (R&D) to bid huge sleep aids
  • 5.1.4. Challenges
    • 5.1.4.1. Absence of appropriate documents for the permitting license
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Sleep Aids Market, by Product

• 6.1. Introduction
• 6.2. Mattresses & Pillows
• 6.3. Medications
  • 6.3.1. Herbal Drugs
  • 6.3.2. OTC Drugs
  • 6.3.3. Prescription-Based Drugs
• 6.4. Sleep Apnea Devices
  • 6.4.1. Adaptive Servo-Ventilators (ASVs)
  • 6.4.2. Facial Interfaces
  • 6.4.3. Oral Appliances
  • 6.4.4. Positive Airway Pressure (PAP) Devices

7. Sleep Aids Market, by Sleep-Disorder

• 7.1. Introduction
• 7.2. Insomnia
• 7.3. Narcolepsy
• 7.4. Restless Legs Syndrome
• 7.5. Sleep Apnea
• 7.6. Sleep Walking

8. Sleep Aids Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Drug Stores
• 8.3. E-Commerce
• 8.4. Hospital Pharmacies
• 8.5. Retail Pharmacies

9. Americas Sleep Aids Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Sleep Aids Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Sleep Aids Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Apnea Sciences Corporation
• 2. Boehringer Ingelheim International GmbH
• 3. Cadwell Industries Inc.
• 4. Cleveland Medical Devices Inc.
• 5. Compumedics Limited
• 6. Drive DeVilbiss Healthcare Inc.
• 7. Eisai Co., Ltd.
• 8. Fisher & Paykel Healthcare Corp. Ltd.
• 9. Koninklijke Philips N. V.
• 10. Merck and Co. Inc.
• 11. Natus Medical Inc.
• 12. Nihon Kohden Corporation
• 13. Pfizer Inc.
• 14. ResMed Inc.
• 15. Sanofi S.A.